Cargando…
Imatinib-induced IgA Pemphigus: Subcorneal Pustular Dermatosis Type
Imatinib mesylate, a tyrosine kinase inhibitor, is commonly used in the treatment of chronic myeloid leukemia. IgA pemphigus is a rare bullous dermatosis caused by IgA autoantibodies. Clinical manifestations include localized or generalized itchy blisters and pustules. Drug-induced IgA pemphigus has...
Autores principales: | Sood, Aradhana, Sinha, Preema, Raman, Deep K., Sinha, Anwita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137662/ https://www.ncbi.nlm.nih.gov/pubmed/30258803 http://dx.doi.org/10.4103/idoj.IDOJ_331_17 |
Ejemplares similares
-
Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
por: Kreyberg, Ina, et al.
Publicado: (2023) -
Subcorneal pustular dermatosis masquerading as dermatophytosis
por: Thomas, Jayakar, et al.
Publicado: (2012) -
Subcorneal pustular dermatosis in the pediatric age
por: Jardim, Márcio Martins Lobo, et al.
Publicado: (2018) -
Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab
por: Chen, Jiaoquan, et al.
Publicado: (2022) -
Subcorneal pustular dermatosis in a 54-year-old woman
por: Xu, Wen-Ting, et al.
Publicado: (2023)